mhurhangee/ep-ind-claims huggingface dataset:
A computer-implemented method comprising: receiving a map update for at least a first tile comprising map update data, the map update comprising updated map data for the first tile and previous map data for the first tile corresponding to all changed or new links intersected by a tile boundary between the first tile and a second tile; determining a map region of interest, the map region of interest comprising at least a portion of the first tile; in response to determining that the map region of interest comprises at least a portion of the second tile, determining if a map update for the second tile has been received; when it is determined that a map update for the second tile has been received, not using or displaying the previous map data for the changed or new links intersected by the tile boundary and using or displaying updated map data for the portion of the first tile within the map region of interest; and when it is determined that a map update for the second tile has not been received, using or displaying the previous map data for the changed or new links intersected by the tile boundary. receiving a map update for at least a first tile comprising map update data, the map update comprising updated map data for the first tile and previous map data for the first tile corresponding to all changed or new links intersected by a tile boundary between the first tile and a second tile; determining a map region of interest, the map region of interest comprising at least a portion of the first tile; in response to determining that the map region of interest comprises at least a portion of the second tile, determining if a map update for the second tile has been received; when it is determined that a map update for the second tile has been received, not using or displaying the previous map data for the changed or new links intersected by the tile boundary and using or displaying updated map data for the portion of the first tile within the map region of interest; and when it is determined that a map update for the second tile has not been received, using or displaying the previous map data for the changed or new links intersected by the tile boundary.
A method for producing a hollow fiber membrane fluid transport device, comprising the steps of: laying polytetrafluoroethylene hollow fibers in an array or a row, applying a fluorinated homopolymer, copolymer, or terpolymer film on the hollow polytetrafluoroethylene fiber array interwoven through interstitial spaces between the fibers near one end or both ends of the hollow polytetrafluoroethylene fibers, rolling the fibers and film into a bundle, heating the bundle to melt the film; compressing a portion of the bundle such that molten film flows between the hollow fibers to form an integral bundle of hollow fibers; and cooling said film and fibers to form a solid mass providing a fluid-tight seal around each fiber such that the ends of the hollow fibers are open on one side of the solid mass and the open fiber ends are isolated from the fiber walls of the membrane. laying polytetrafluoroethylene hollow fibers in an array or a row, applying a fluorinated homopolymer, copolymer, or terpolymer film on the hollow polytetrafluoroethylene fiber array interwoven through interstitial spaces between the fibers near one end or both ends of the hollow polytetrafluoroethylene fibers, rolling the fibers and film into a bundle, heating the bundle to melt the film; compressing a portion of the bundle such that molten film flows between the hollow fibers to form an integral bundle of hollow fibers; and cooling said film and fibers to form a solid mass providing a fluid-tight seal around each fiber such that the ends of the hollow fibers are open on one side of the solid mass and the open fiber ends are isolated from the fiber walls of the membrane.
A composition comprising nanoparticles that comprise rapamycin or a derivative thereof and a carrier protein for use in a method of treating cancer in an individual, wherein the method further comprises a second therapy, wherein the second therapy comprises administration of erlotinib, perifosine or doxorubicin, and wherein the derivative is selected from the group consisting of benzoyl rapamycin, oxaazacyclohentriacontine, temsirolimus (CCI 779 (Wyeth)), everolimus (RAD 001 (Novartis)), pimecrolimus, 32-deoxo rapamycin, zotarolimus (ABT-578), ridaforolimus, and Biolimus A9.
A method of transmitting an uplink signal by a user equipment, UE, in a wireless communication system, the method comprising: receiving a downlink channel comprising a timing advance, TA, command related to an index value for performing a timing advance operation by the UE; determining a TA value for the timing advance operation based on (i) the TA command and (ii) a basic unit of the TA value, transmitting the uplink signal according to the timing advance operation based on the TA value, wherein the TA value is configured to (i) increase as the index value indicated by the TA command increases, and (ii) decrease as the largest value among the subcarrier spacing values increases characterized in that the basic unit of the TA value is determined based on a largest value among subcarrier spacing values of the plurality of uplink bandwidth parts of the UE. receiving a downlink channel comprising a timing advance, TA, command related to an index value for performing a timing advance operation by the UE; determining a TA value for the timing advance operation based on (i) the TA command and (ii) a basic unit of the TA value, transmitting the uplink signal according to the timing advance operation based on the TA value, wherein the TA value is configured to (i) increase as the index value indicated by the TA command increases, and (ii) decrease as the largest value among the subcarrier spacing values increases
A method for transporting a gas from a production point to a use point, the method including: • a gas liquefaction step in which the gas is cooled to a temperature lower than a liquefaction temperature of said gas in a heat exchange unit, • a step of transporting the liquefied gas to the use point, the heat exchange unit is close to the production point and frigories coming from a medium stored beforehand in a tank mounted on a vehicle proximate to the heat exchange unit are used for cooling in the heat exchange unit, characterized in that the tank is a unique tank separated by a removable wall so as to form a medium tank and a liquefied gas tank. • a gas liquefaction step in which the gas is cooled to a temperature lower than a liquefaction temperature of said gas in a heat exchange unit, • a step of transporting the liquefied gas to the use point,
Process for producing a patient specific pad for a modular constructed bracket having a pad and a bracket body, which comprises the steps: a) providing a preferably flat pad material section, b) providing a blanking press having at least one punch for blanking at least one raw pad out of the pad material section, c) blanking of raw pads out of the pad material section by means of the blanking press and providing a raw pad library with these raw pads having a row of at least 14 raw pad containers, each containing raw pads for a tooth of an upper jaw as well as a row of at least 14 raw pad containers, each containing raw pads for a tooth of a lower jaw, wherein in the raw pad library for at least one tooth there is arranged at least one further raw pad container in which raw pads of a further size and/or with wing sections (5m, 5d) and/or with half occlusal sections are arranged, d) producing a patient specific set-up, especially of plaster, of teeth of an upper jaw and/or of a lower jaw to be treated of a patient, e) selecting a raw pad from the raw pad library for a tooth to be treated of the patient, and f) filling a gap between the raw pad and the pertaining tooth in a set-up using a filling material, especially of polymer, for producing for the pad a tooth specific adherend surface allowing for a form fit to the clinical tooth of the patient. a) providing a preferably flat pad material section, b) providing a blanking press having at least one punch for blanking at least one raw pad out of the pad material section, c) blanking of raw pads out of the pad material section by means of the blanking press and providing a raw pad library with these raw pads having a row of at least 14 raw pad containers, each containing raw pads for a tooth of an upper jaw as well as a row of at least 14 raw pad containers, each containing raw pads for a tooth of a lower jaw, wherein in the raw pad library for at least one tooth there is arranged at least one further raw pad container in which raw pads of a further size and/or with wing sections (5m, 5d) and/or with half occlusal sections are arranged, d) producing a patient specific set-up, especially of plaster, of teeth of an upper jaw and/or of a lower jaw to be treated of a patient, e) selecting a raw pad from the raw pad library for a tooth to be treated of the patient, and f) filling a gap between the raw pad and the pertaining tooth in a set-up using a filling material, especially of polymer, for producing for the pad a tooth specific adherend surface allowing for a form fit to the clinical tooth of the patient.
An apparatus for playing a game where players jump or skip to avoid a moving beam, the apparatus comprising; a stationary base section; a moveable portion coupled to the base section, the moveable portion being configured to emit a moving beam of radiation, a detector configured to detect the beam of radiation; a central processor configured to control the movement of the moveable portion; and a device arranged to be worn by a player, wherein the device is configured to send a signal to the detector in response to interaction with the moving beam, characterised in that the moveable portion is configured to rotate through a full 360 degrees so that the beam sweeps through a full 360 degrees, wherein the rotation direction is controlled to change randomly throughout the game. a stationary base section; a moveable portion coupled to the base section, the moveable portion being configured to emit a moving beam of radiation, a detector configured to detect the beam of radiation; a central processor configured to control the movement of the moveable portion; and a device arranged to be worn by a player, wherein the device is configured to send a signal to the detector in response to interaction with the moving beam, characterised in that the moveable portion is configured to rotate through a full 360 degrees so that the beam sweeps through a full 360 degrees, wherein the rotation direction is controlled to change randomly throughout the game. the device is configured to send a signal to the detector in response to interaction with the moving beam, characterised in that the moveable portion is configured to rotate through a full 360 degrees so that the beam sweeps through a full 360 degrees, wherein the rotation direction is controlled to change randomly throughout the game.
A centering bolt for producing a flange joint between two components (146, 148) of a wind turbine, in particular between a rotor blade and a rotor hub, or between a rotor shaft and a rotor hub, comprising - a shaft, wherein the shaft has - a longitudinal axis, and, - along the longitudinal axis a first portion having a first outside diameter, and a second portion following the first portion, which has a smaller second outside diameter as compared to the first outside diameter, - a centering sleeve pushed onto the second portion of the shaft, wherein the centering sleeve - is mounted to the shaft rotatably about the longitudinal axis, - is axially secured against shifting with respect to the longitudinal axis, - has a sleeve outside diameter which is larger than the first outside diameter, wherein the centering bolt, for producing the flange joint, is formed to be mounted in two mutually aligned bores (152, 154) of flange connections (128, 150) of the two components (146, 148) to be joined, in such a manner that the centering sleeve is arranged within the two aligned bores (152, 154) for centering the components (146, 148). - a shaft, wherein the shaft has - a longitudinal axis, and, - along the longitudinal axis a first portion having a first outside diameter, and a second portion following the first portion, which has a smaller second outside diameter as compared to the first outside diameter, - a longitudinal axis, and, - along the longitudinal axis a first portion having a first outside diameter, and a second portion following the first portion, which has a smaller second outside diameter as compared to the first outside diameter, - a centering sleeve pushed onto the second portion of the shaft, wherein the centering sleeve - is mounted to the shaft rotatably about the longitudinal axis, - is axially secured against shifting with respect to the longitudinal axis, - has a sleeve outside diameter which is larger than the first outside diameter, - is mounted to the shaft rotatably about the longitudinal axis, - is axially secured against shifting with respect to the longitudinal axis, - has a sleeve outside diameter which is larger than the first outside diameter,
A vapor deposition mask device comprising a vapor deposition mask having an effective region in which a plurality of first through holes is arranged, and a frame attached to the vapor deposition mask, wherein the vapor deposition mask device includes a plurality of joint portions which joins the vapor deposition mask and the frame to each other, the plurality of joint portions is arranged along an outer edge of the vapor deposition mask, a notch is formed, in the outer edge of the vapor deposition mask, at a position corresponding to between two of the joint portions which are adjacent, characterized in that the notch extends beyond an inner edge of the frame in plan view of the vapor deposition mask. the vapor deposition mask device includes a plurality of joint portions which joins the vapor deposition mask and the frame to each other, the plurality of joint portions is arranged along an outer edge of the vapor deposition mask, a notch is formed, in the outer edge of the vapor deposition mask, at a position corresponding to between two of the joint portions which are adjacent, characterized in that the notch extends beyond an inner edge of the frame in plan view of the vapor deposition mask.
A composition comprising an effective amount of plasminogen for use in the prevention and/or treatment of hepatic tissue injury caused by diabetes, radiation or chemical toxicants.
A pig handling device with a housing, a cavity which can be found in the housing and in which a pig can be received, a connection by means of which the cavity can be connected to a processing system and which is suitable for allowing the pig to pass through, and with at least one handling element (30, 50) which is arranged in the cavity, is designed to influence the mobility of the pig in the cavity, and has at least one base element (32, 52) that has a first surface (70, 70') and at least one functional element (34, 54, 56) that is connected to the base element (32, 52) in the cavity and has a second surface (72, 72'), characterized in that the handling element (30, 50) has a concavely curved transition surface (74, 74'), which is arranged between the first surface (70, 70') and the second surface (72, 72') and which comprises a core curvature region (76, 76'), and the base element (32, 52) and the functional element (34, 54, 56) are bonded to one another outside of the core curvature region (76, 76').
A process to manufacture an ophthalmic lens containing a Fresnel surface inside the lens comprising the steps of: injection molding a first thermoplastic material with a microstructured mold insert (146a, 146b) to provide a first microstructured lens having a Fresnel surface; and overmolding a second thermoplastic material which is different than the first thermoplastic material on to said first lens to provide the ophthalmic lens; characterized in that the microstructured mold insert has a heat conductivity that is lower than the heat conductivity of the first thermoplastic material; the microstructured lens is molded at fixed mold temperature, which is below first material's glass transition temperature; and the microstructured mold insert is a hybrid mold insert comprising a Nickel microstructured shim bonded to a ceramic pillar or a plastic mold insert removably mounted on a support pillar, wherein the plastic is a further thermoplastic material which avoids adherence to the first thermoplastic material. injection molding a first thermoplastic material with a microstructured mold insert (146a, 146b) to provide a first microstructured lens having a Fresnel surface; and overmolding a second thermoplastic material which is different than the first thermoplastic material on to said first lens to provide the ophthalmic lens;
Compression orthosis comprising a tubular sleeve in particular knit from elastic yarn, covering at least the arm and the hand, at least up to the insertion of the phalanges on the metacarpal bones of the hand, and a protrusion intended to at least partially cover the thumb over its entire circumference, the tubular sleeve and the protrusion being knit into one piece, characterised in that the protrusion is knit at least in part from the yarn(s) thermobonding at a T1 temperature; said T1 temperature being comprised between 100 and 130°C and; said tubular sleeve and protrusion containing the same combination of textile fibres with exception of the yarn thermobonding at the T1 temperature that is present in the protrusion only.
A method for determining the prognosis of an individual having cancer and currently being treated with one or more immune checkpoint inhibitors, the method comprising or consisting of the steps of: a) providing a sample obtained from the individual prior to treatment with one or more immune checkpoint inhibitors; b) measuring the activity and/or concentration of thymidine kinase in the sample; c) providing a sample obtained from the individual 1-4 weeks after first treatment with the one or more immune checkpoint inhibitors; and d) measuring the activity and/or concentration of thymidine kinase in the sample provided in step (c); wherein the activity and/or concentration of thymidine kinase measured in steps (b) and (d) is indicative of the prognosis of the individual if further treated with one or more immune checkpoint inhibitors, wherein the prognosis of the individual if further treated with one or more checkpoint inhibitors is positive when the activity and/or concentration of thymidine kinase measured in step (d) is increased compared to the activity and/or concentration of thymidine kinase measured in step (b). a) providing a sample obtained from the individual prior to treatment with one or more immune checkpoint inhibitors; b) measuring the activity and/or concentration of thymidine kinase in the sample; c) providing a sample obtained from the individual 1-4 weeks after first treatment with the one or more immune checkpoint inhibitors; and d) measuring the activity and/or concentration of thymidine kinase in the sample provided in step (c);
A robotic surgical tool comprising: a tool housing; an elongate shaft coupled to and extending from the tool housing, the elongate shaft further defining a lumen that extends between a proximal end and a distal end of the elongate shaft; and a latching mechanism arranged on the elongate shaft and comprising one or more retention tabs that are biased radially outward with one or more biasing members; wherein the one or more retention tabs are movable between a deployed state, in which the one or more retention tabs extend radially outward from the elongate shaft and are positioned to engage an exterior surface of a mounting fixture of a robotic manipulator, and a retracted state, in which the one or more retention tabs are urged radially inward and are positioned to disengage the exterior surface of the mounting fixture; characterised in that the robotic surgical tool further comprises a plurality of elongate members extending through the lumen and operably engaging an end effector coupled to the distal end of the elongate shaft; wherein a component of the one or more biasing members or the one or more retention tabs is configured to engage one or more of the elongate members when the one or more retention tabs are in the retracted state. a tool housing; an elongate shaft coupled to and extending from the tool housing, the elongate shaft further defining a lumen that extends between a proximal end and a distal end of the elongate shaft; and a latching mechanism arranged on the elongate shaft and comprising one or more retention tabs that are biased radially outward with one or more biasing members; wherein the one or more retention tabs are movable between a deployed state, in which the one or more retention tabs extend radially outward from the elongate shaft and are positioned to engage an exterior surface of a mounting fixture of a robotic manipulator, and a retracted state, in which the one or more retention tabs are urged radially inward and are positioned to disengage the exterior surface of the mounting fixture; characterised in that the robotic surgical tool further comprises a plurality of elongate members extending through the lumen and operably engaging an end effector coupled to the distal end of the elongate shaft; wherein a component of the one or more biasing members or the one or more retention tabs is configured to engage one or more of the elongate members when the one or more retention tabs are in the retracted state.
A glass fiber reinforced polyamide resin composition comprising: 45 to 50 wt% of a polyamide resin, based on 100 wt% in total of the composition; a styrene-maleimide based copolymer having a thermal decomposition temperature of 300°C or more, as measured with a thermogravimetric analyzer, and wherein an amount of the styrene-maleimide based copolymer is 0.1 to 5 wt%, based on 100 wt% in total of the composition; 15 to 25 wt% of a halogen-based flame retardant, based on 100 wt% in total of the composition; and 20 to 25 wt% of glass fiber, based on 100 wt% in total of the composition; wherein the polyamide resin is a mixture of a poly hexamethylene diamine adipamide (nylon 6,6) and poly caprolactam (nylon 6), and wherein a weight ratio of the poly hexamethylene diamine adipamide (nylon 6,6) to the poly caprolactam (nylon 6) is 29:71 to 31:69. 45 to 50 wt% of a polyamide resin, based on 100 wt% in total of the composition; a styrene-maleimide based copolymer having a thermal decomposition temperature of 300°C or more, as measured with a thermogravimetric analyzer, and wherein an amount of the styrene-maleimide based copolymer is 0.1 to 5 wt%, based on 100 wt% in total of the composition; 15 to 25 wt% of a halogen-based flame retardant, based on 100 wt% in total of the composition; and 20 to 25 wt% of glass fiber, based on 100 wt% in total of the composition; wherein the polyamide resin is a mixture of a poly hexamethylene diamine adipamide (nylon 6,6) and poly caprolactam (nylon 6), and wherein a weight ratio of the poly hexamethylene diamine adipamide (nylon 6,6) to the poly caprolactam (nylon 6) is 29:71 to 31:69.